Taylor & Francis Group

SHERPA: Unknown

People

  1. Bewersdorf
    Bewersdorf
  2. Derkach
    Derkach
  3. Goldberg
    Goldberg
  4. Kumar
    Kumar
  5. Salles
    Salles
  6. Stein
    Stein
  7. Daniyan
    Daniyan
  8. Dogan
    Dogan
  9. Epstein-Peterson
    Epstein-Peterson
  10. Geyer
    Geyer

Groups

  1. GME, Medicine (10)
  2. Graduate Medical Education (10)
  3. Hematology-Oncology Fellows (10)
  4. Department of Medicine (9)
  5. Center for Hematologic Malignancies (8)
  6. Hematologic Malignancies, Division of (8)
  7. Adult Leukemia (4)
  8. Lymphoma (4)
  9. Biostatistics Service (3)
  10. Epidemiology and Biostatistics (3)
Search Within
  1. "Hematology-Oncology Fellows"
Formats
  1. Journal Article (3)
  2. Review (3)
  3. Editorial (2)
  4. Correspondence (1)
  5. Research Letter (1)
Groups
  1. GME, Medicine (10)
  2. Graduate Medical Education (10)
  3. Hematology-Oncology Fellows (10)
  4. Department of Medicine (9)
  5. Center for Hematologic Malignancies (8)
  6. Hematologic Malignancies, Division of (8)

More Groups

People
  1. Jan Bewersdorf (4)
  2. David Qualls (3)
  3. Aaron Goldberg (2)
  4. Ahmet Dogan (2)
  5. Andriy Derkach (2)
  6. Anita Kumar (2)

More People

Years
  1. 2023 (4)
  2. 2022 (3)
  3. 2021 (2)
  4. 2020 (1)
Publications
  1. Leukemia and Lymphoma (7)
  2. Expert Review of Anticancer Therapy (2)
  3. Expert Review of Hematology (1)

Results (10)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecularly targeted epigenetic therapy with mocetinostat in relapsed and refractory non-Hodgkin lymphoma with CREBBP or EP300 mutations: An open label phase II study
    Research Letter

    Qualls, D.; Noy, A.; Straus, D.; Matasar, M.; Moskowitz, C.; Seshan, V.; Dogan, A.; Salles, G.; Younes, A.; Zelenetz, A. D.; more...
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Personalized approaches for treatment-naìˆve mantle cell lymphoma
    Review

    Qualls, D.; Kumar, A.
    Expert Review of Hematology (2023)

    Fulltext@MSK | Save
  • Cost-effectiveness of azacitidine and ivosidenib in newly diagnosed older, intensive chemotherapy-ineligible patients with IDH1-mutant acute myeloid leukemia
    Journal Article

    Bewersdorf, J. P.; Patel, K. K.; Goshua, G.; Shallis, R. M.; Podoltsev, N. A.; Stahl, M.; Stein, E. M.; Huntington, S. F.; Zeidan, A. M.
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Venetoclax-based salvage therapy in patients with relapsed/refractory acute myeloid leukemia previously treated with FLT3 or IDH1/2 inhibitors
    Journal Article

    Bewersdorf, J. P.; Shallis, R. M.; Derkach, A.; Goldberg, A. D.; Stein, A.; Stein, E. M.; Marcucci, G.; Zeidan, A. M.; Shimony, S.; DeAngelo, D. J.; more...
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Targeting the immune microenvironment in mantle cell lymphoma: Implications for current and emerging therapies
    Review

    Qualls, D.; Kumar, A.; Epstein-Peterson, Z. D.
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • CD19 epitope masking by tafasitamab leads to delays in subsequent use of CD19 CAR T-cell therapy in two patients with aggressive mature B-cell lymphomas
    Correspondence

    Fitzgerald, K. N.; Quesada, A. E.; von Keudell, G.; Raj, S.; Lewis, N. E.; Dogan, A.; Salles, G.; Palomba, M. L.
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Myeloid-derived suppressor cells: A grey eminence in the AML tumor microenvironment?
    Editorial

    Bewersdorf, J. P.; Zeidan, A. M.
    Expert Review of Anticancer Therapy (2022)

    Fulltext@MSK | Save
  • Does the conventional cytogenetic risk profile still matter for prediction of venetoclax based treatment outcomes in AML?
    Editorial

    Bewersdorf, J. P.; Stone, R. M.; Tallman, M. S.; Stahl, M.
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save
  • Neutropenia in adult acute myeloid leukemia patients represents a powerful risk factor for COVID-19 related mortality
    Journal Article

    Stahl, M.; Narendra, V.; Jee, J.; Derkach, A.; Maloy, M.; Geyer, M. B.; Mato, A. R.; Roeker, L. E.; Tallman, M. S.; Shah, G. L.; more...
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save
  • The emerging role of antibody-drug conjugates in urothelial carcinoma
    Review

    Lattanzi, M.; Rosenberg, J. E.
    Expert Review of Anticancer Therapy (2020)

    Fulltext@MSK | Save